Publication | Closed Access

PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients

Breast OncologyMedicinePathologyBreast CancerCdk4/6 InhibitorsCancer TreatmentMolecular DiagnosticsCancer GeneticsOncologyCell BiologyLiquid BiopsyTumor BiologyPi3k Mutations